"Avec une communauté de près de 16 000 professionnels, le CHU de Lille est l’un des plus grands campus santé du Nord de l’Europe. Hôpital universitaire de recours et de référence, d’enseignement, d’innovation et de recherche, il prend en charge des pathologies lourdes nécessitant un plateau médico-technique de pointe et une expertise médicale spécialisée. Près de 1.4 millions de patients y sont pris en charge chaque année, permettant au CHU de Lille de développer une expertise à la fois pour ses activités de recours et pour celles de proximité."

During the past decade, CHU de LILLE-Hôpital Claude HURIEZ-Service d'Endocrinologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de LILLE-Hôpital Claude HURIEZ-Service d'Endocrinologie" #1 collaborator was "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CHU de LILLE-Hôpital Claude HURIEZ-Service d'Endocrinologie" are "Adult Phenylketonuria Non Treated Patients" (1 trials), "Hyperphenylalaninemia" (1 trials) and "PKU" (1 trials). Many other conditions were trialed in "CHU de LILLE-Hôpital Claude HURIEZ-Service d'Endocrinologie" in a lesser frequency.

Most popular intervention types in "CHU de LILLE-Hôpital Claude HURIEZ-Service d'Endocrinologie" are "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dietary Supplement for PKU patients" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU de LILLE-Hôpital Claude HURIEZ-Service d'Endocrinologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CHU de LILLE-Hôpital Claude HURIEZ-Service d'Endocrinologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CHU de LILLE-Hôpital Claude HURIEZ-Service d'Endocrinologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU de LILLE-Hôpital Claude HURIEZ-Service d'Endocrinologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".